# OnCo record thyrotropin-alfa (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/thyrotropin-alfa/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "thyrotropin-alfa" ;
  schema:name "Thyrotropin alfa"@en ;
  schema:alternateName "Recombinant human TSH"@en, "rhTSH"@en, "Thyrogen" ;
  schema:description "Thyrogen is an injected version of thyroid-stimulating hormone that lets people with thyroid cancer have radioiodine treatment and follow-up blood tests without stopping their thyroid hormone tablets and suffering weeks of hypothyroidism."@en ;
  schema:url <https://onco.cc/drugs/thyrotropin-alfa/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Thyrotropin_alfa> ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/thyrogen>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=thyrotropin%20alfa> ;
  onco:status "approved" ;
  onco:tag "ema-list", "supportive" ;
  onco:modality "Recombinant human thyroid-stimulating hormone" ;
  onco:approval "US 1998: Adjunctive diagnostic tool for thyroglobulin testing in well-differentiated thyroid cancer; pre-therapeutic stimulation for radioiodine remnant ablation added 2007", "EU 2000: Thyroglobulin testing and radioiodine imaging in thyroid cancer follow-up; pre-therapeutic stimulation for radioiodine ablation" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/radioiodine-therapy/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:terms <https://onco.cc/terms/radioiodine-term/> ;
  onco:trials <https://onco.cc/trials/nct04964284/>, <https://onco.cc/trials/nct04971473/>, <https://onco.cc/trials/nct00295763/> .